Figure 3.
Response of a bio-naïve patient to dupilumab treatment over time: (a) patient at Week 0; (b) after 16 weeks of treatment. Consent to publish was obtained from the individual featured.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.